fashion -WSS

fashion

author：comprehensive 2025-09-06 03:32:47 - browse：99369

Drug shortages are a growing problem in the U.S., and a shortage of livesaving cancer drugs in particular has reached crisis levels.

On the latest episode of the “First Opinion Podcast,” oncologist Kristen Rice explains that drug shortages have been happening for several years but have been progressively worsening in the past few months. Oncologists are facing critical shortages of common, generic cancer medications and have even begun to ration care for certain patients who are able to delay treatment, according to Rice.

“Patients are already under a lot of stress — they’re dealing with a cancer diagnosis, and they’re terrified. The last thing they want to hear is that something that’s critical to controlling their cancer might not be available, and we’re wondering where the next dose is going to come from,” Rice said.

The conversation is based off Rice’s recent First Opinion, “Cancer drug shortages should have patients rioting in the streets.“

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： How AI helped researchers track recovery from depression

focus

hotspot

WSS

What Congress can do to address the rural doctor shortage

BD to buy Edwards patient monitoring unit for $4.2 billion

Readout LOUD podcast: possible new ALS drug, artificial wombs

Senate HELP committee spars over health care workforce policies

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

'Little Tech' descents on D.C., wanting a say in how AI is regulated

knowledge

fashion

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Guidelines to prevent youth baseball injuries need more muscle

STAT wants to know your pick for a great summer read or listen

How one medical school became remarkably diverse

How Vertex's cystic fibrosis drug is changing patients' lives

Bright Health sells Medicare Advantage business to Molina

Changes to biosimilar regulatory framework must prioritize patients

Heart attack and stroke risk calculators need revising

Biotech stock slump in 2023: awaiting the turnaround

hotspot

FTC loses bid to block Novant's North Carolina hospital merger

Sutter Health’s antitrust win overturned by appeals court

Senate HELP committee spars over health care workforce policies

Senators: Long

Hearing on Medicare drug price negotiation gets unusually heated

ASCO Daily Recap: CAR

focus

hotspot

focus

explore